European Medical Journal - European Medical Journal
×

Browse

23
Jun

Newborn Screening: Now and in the Future
Reproductive Health
WHAT is the value of newborn screening (NBS) to the rare diseases community?…
23
Jun

Driving Care Pathways into the Future
Innovations
ARTIFICIAL intelligence could one day form the backbone of healthcare, but with such a powerful technology looming on our horizon, what exactly does this…
23
Jun

Disruptive Innovations in Clinical Research
Innovations
DISRUPTIVE innovation, that is, innovation that overturns or otherwise challenges the status quo, was a theme explored in a session at this year’s 10th…
23
Jun

Early Intervention with Anti-Tumour Necrosis Factor in Ulcerative Colitis: The Missing Piece of The Puzzle?
Gastroenterology
In an interactive symposium moderated by Dr Cummings, the question: “Is early intervention with anti-TNF the key to achieving long-lasting remission…
23
Jun

Eicosapentaenoic Acid: Atheroprotective Properties and the Reduction of Atherosclerotic Cardiovascular Disease Events
Cardiology
Atherosclerosis is an inflammatory disease and inflammation is crucial to all stages of atherogenesis. Targeting inflammation has the potential to reduce…
23
Jun

Chlormethine Gel for Mycosis Fungoides T-cell Lymphoma: Recent Real-World Data
Dermatology
An enhanced understanding of real-world CL Gel usage could help improve the management of patients with MF-CTCL…
23
Jun

Data from the AUGUSTUS Trial Adds an Important Piece to the Complex Puzzle of Antithrombotic Treatment for Those with Nonvalvular Atrial Fibrillation with Acute Coronary Syndrome and/or Percutaneous Coronary Intervention
Cardiology
AF can increase stroke risk and is generally treated with OAC therapy, such as with a VKA or a direct OAC (DOAC). However, what if someone with AF…
23
Jun

Oral Prostacyclin Pathway Agents in Pulmonary Arterial Hypertension: An Expert Clinical Consensus
Cardiology
PAH is a rare, progressive disorder with a number of aetiologies. Approximately 15–60 patients per million of the global population are affected…